Why Are There No Treatment Guidelines for Mood Disorders and Comorbidities?

Kessler RC , Üstün TB . The WHO World Mental Health Surveys: Global Perspectives on the Epidemiology of Mental Disorders. New York, NY: Cambridge University Press; 2008.

Merikangas KR , Jin R , He JP , . Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68:241–251.

Collins PY , Patel V , Joestl SS , . Grand challenges in global mental health. Nature. 2011;475:27–30.

Demyttenaere K , Bruffaerts R , Posada-Villa J , . Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA. 2004;291:2581–2590.

Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis. 1970;23:455–468.

Kessler RC , Birnbaum HG , Shahly V , . Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey Initiative. Depress Anxiety. 2010;27:351–364.

Magalhães PV Kapczinski F , Nierenberg AA , . Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder [published online ahead of print November 19, 2011]. Acta Psychiatr Scand. doi: 10.1111/j.1600-0447.2011.01794.x.

McDermut W , Mattia J , Zimmerman M. Comorbidity burden and its impact on psychosocial morbidity in depressed outpatients. J Affect Disord. 2001;65:289–295.

Benton T , Staab J , Evans DL. Medical co-morbidity in depressive disorders. Ann Clin Psychiatry. 2007;19:289–303.

Rush AJ , Warden D , Wisniewski SR , . STAR*D: revising conventional wisdom. CNS Drugs. 2009;23:627–647.

Hirschfeld RM , Vornik LA. Bipolar disorder—costs and comorbidity. Am J Manag Care. 2005;11:S85–S90.

Kennedy SH , Lam RW , Parikh SV , . Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. J Affect Disord. 2009;117:S1–S64.

Yatham LN , Kennedy SH , Schaffer A , . Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord. 2009;11:225–255.

Davidson JR. Major depressive disorder treatment guidelines in America and Europe. J Clin Psychiatry. 2010;71:e04.

Connolly KR , Thase ME. The clinical management of bipolar disorder: a review of evidence-based guidelines. Prim Care Companion CNS Disord. 2011;13.

Zetin M , Hoepner CT. Relevance of exclusion criteria in antidepressant clinical trials: a replication study. J Clin Psychopharmacol. 2007;27:295–301.

Lugtenberg M , Burgers JS , Clancy C , . Current guidelines have limited applicability to patients with comorbid conditions: a systematic analysis of evidencebased guidelines. PLo S One. 2011;6:e25987.